Seattle Children’s Research Institute opened the $300 million Building Cure in October of 2019. The 540,000-sf translational research facility provides advanced laboratories for the development of innovative treatments for pediatric cancer, sickle cell anemia, ADHD, and diabetes. One entire floor of the building houses the Cure Factory, a GMP cell-therapy manufacturing center for the creation of personalized medicine solutions.
Purdue University will begin construction in spring of 2020 on the $108 million Veterinary Teaching Hospital in West Lafayette, Ind. Accommodating equine, small animal, and farm animal patients, the 175,290-gsf facility will support translational research programs to enable the development of new therapeutics and technologies that may have applications for human health.
Grand River Aseptic Manufacturing (GRAM) is constructing a $60 million facility in Grand Rapids, Mich. Designed by CRB, the 61,500-sf facility will include a state-of-the-art cleanroom, two formulation suites, and 14,000 sf of shell space to accommodate future growth. Capable of producing a wide range of commercial batch sizes, the aseptic manufacturing plant will integrate leading-edge automation technologies and high-speed instrumentation to support the production of parenteral medicinal solutions.
The University of New Mexico completed construction of the $67 million Physics, Astronomy, and Interdisciplinary Science Center in Albuquerque in October of 2019. Designed by EYP Architecture & Engineering and Van H. Gilbert, the 139,100-gsf facility houses the department of physics and astronomy as well as accommodating research programs in bioinformatics, genomics, electron microscopy, optics, spatial informatics, stable isotopes, and human and primate biomedical research.
Beacon Pharmaceuticals is planning to break ground by early 2020 on a 150,000-sf biosciences accelerator and headquarters facility in Jupiter, Fla. Designed by Kobi Karp Architecture & Interior Design, the $80 million facility will feature a pharmaceutical business incubator to support early-stage companies from concept to commercialization.
Texas Tech University opened the $77 million Experimental Sciences Building II in October of 2019 in Lubbock, Texas. Comprising four stories and a basement level, the 117,000-gsf facility provides collaborative environments for interdisciplinary research including four general wet labs, three core instrumentation suites, two synthetic labs, a vivarium, a BSL-2 lab, conference rooms, and offices for researchers and principal investigators.
The University of Oklahoma opened the 75,500-sf Gallogly Hall in late September of 2019 in Norman. Designed by Page Southerland Page to house the Stephenson School of Biomedical Engineering, the facility provides technology-rich classrooms and teaching labs, a large lecture hall, a maker space, faculty and graduate student offices, interactive learning venues, and a rooftop terrace.
Mayo Clinic opened the $32.4 million Discovery and Innovation Building in late August of 2019 in Jacksonville, Fla. Developed in collaboration with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation, the 75,000-sf facility features three ex-vivo lung perfusion (EVLP) suites to test and prepare lungs for transplantation. The three-story building also includes collaborative biomedical research space, an automated stem cell manufacturing hub, and a life science incubator with wet labs and co-working space.
Pennsylvania State University is planning to construct the $98.5 million Animal, Veterinary and Biomedical Sciences Building in University Park. Designed by HOK, the 105,000-sf facility will provide the College of Agricultural Sciences with research labs, a general-purpose classroom, faculty offices, seminar rooms, and a state-of-the-art vivarium.
The University of Warwick is planning to build the £54.3 million Interdisciplinary Biomedical Research Building in Coventry in the United Kingdom. Designed by Hawkins\Brown, the 75,000-sf facility will include flexible open labs for up to 300 researchers, a 400-seat lecture hall, a café, a large public entrance, and exhibition space. The five-story building will offer a central ‘lab village’ core, with offices and collaboration zones located on the perimeter to activate the façade.
Pfizer is initiating a $500 million expansion of its Sanford campus with the construction of a 100,000-sf gene therapy facility. Supporting the creation of innovative treatments for genetic diseases, the project will feature advance manufacturing technologies for clinical and commercial-scale production of recombinant adeno-associated virus (rAAV) vectors. Accommodating 300 new employees, the facility will complement operations at the existing 628,000-sf Sanford complex and at the company's Chapel Hill and Kit Creek locations.
Amgen broke ground in late July of 2019 on a $200 million biomanufacturing center in West Greenwich, R.I. Featuring a highly flexible, modular design, the next-generation facility will leverage advanced technologies to reduce operational expenses, consume 80 percent less energy and water, and achieve a 75 percent decrease in carbon emissions.
DLJ Real Estate Capital Partners and Leggat McCall Properties are building a Class-A laboratory building in Somerville, Mass. The nine-story, 289,000-sf facility will provide leading-edge research and office space for life sciences and technology companies. The mixed-use development will include dedicated retail space on the ground floor and four levels of underground parking.
HALIX is constructing a 72,000-sf cGMP facility at Leiden Bio Science Park in the Netherlands. Utilizing 1000-liter, single-use bioreactors, the five-story building will accommodate the development and manufacture of biopharmaceutical drug substances for clinical and commercial applications. Housing labs for process development, analytical development, and quality control, the structure will feature cleanrooms with unidirectional process flows with separate areas for protein manufacturing and the production of viral vaccines and viral vectors.
Adaptive Biotechnologies is expanding its presence in Seattle with the lease of a 100,000-sf headquarters building in Seattle. The lab and office facility is located in the Lake Union life science district and is being developed by Alexandria Real Estate Equities. Adaptive will occupy the entire structure, which is sited adjacent to its existing facility. Building amenities will include an open-air plaza, a rooftop desk, a fitness center, locker and shower rooms, and direct access to water sports on Lake Union.
